Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$7.36 - $9.87 $110,400 - $148,050
-15,000 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$3.95 - $7.4 $59,250 - $111,000
15,000 New
15,000 $74,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $654M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Requisite Capital Management, LLC Portfolio

Follow Requisite Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Requisite Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Requisite Capital Management, LLC with notifications on news.